To demonstrate that our anti-DLK1 mAb could be internalized efficiently, we quantified the cellular internalization rates of DLK1 antibody across ACC cell lines with varying DLK1 expression levels using imaging flow cytometry. This evidence concerns the gene DLK1 and adrenal cortex carcinoma.